SCHEMBL17853247

SCHEMBL17853247

CC1(C)c2cc(-c3ccc4ccccc4c3)ccc2-c2ccc(N(c3cccc(-c4ccc5oc6ccccc6c5c4)c3)c3ccccc3-c3ccc(-c4ccccc4)cc3)cc21

nearest known ligand 0.32

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PGR P06401 1/20 0.32
PLA2G2A P14555 2/20 0.31
PLA2G4A P47712 2/20 0.31
CASP3 P42574 1/20 0.31
SENP7 Q9BQF6 1/20 0.31
SENP6 Q9GZR1 1/20 0.31
ANO1 Q5XXA6 1/20 0.31
HSP90AA1 P07900 1/20 0.31
HSP90AB1 P08238 1/20 0.31
CHRNA1 P02708 1/20 0.31
CHRNG P07510 1/20 0.31
CHRNB1 P11230 1/20 0.31
CHRNB2 P17787 1/20 0.31
SLC6A2 P23975 1/20 0.31
CHRNB4 P30926 1/20 0.31
SLC6A4 P31645 1/20 0.31
CHRNA3 P32297 1/20 0.31
CHRNA4 P43681 1/20 0.31
SLC6A3 Q01959 1/20 0.31
CHRND Q07001 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17733384 0.99 CASP3 (0.31) PGRPLA2G2APLA2G4ACASP3SENP7
SCHEMBL17853239 0.96 PGR (0.33) PGRPLA2G2APLA2G4ACASP3SENP7
SCHEMBL17733255 0.96 PGR (0.33) PGRPLA2G2APLA2G4ACASP3SENP7
SCHEMBL17853233 0.95 PGR (0.33) PGRPLA2G2APLA2G4AANO1HSP90AA1
SCHEMBL17733273 0.94 ALK (0.32) PGRHSP90AA1HSP90AB1CHRNA1CHRNG
SCHEMBL17733223 0.94 PLA2G2A (0.34) PGRPLA2G2APLA2G4AHSP90AA1HSP90AB1
SCHEMBL17853232 0.94 PLA2G2A (0.34) PGRPLA2G2APLA2G4AHSP90AA1HSP90AB1
SCHEMBL17853200 0.94 PLA2G2A (0.34) PGRPLA2G2APLA2G4AHSP90AA1HSP90AB1
SCHEMBL17853256 0.93 CA12 (0.33) PLA2G2APLA2G4AHSP90AA1HSP90AB1CHRNA1
SCHEMBL10110395 0.93 PGR (0.34) PGRPLA2G2APLA2G4ACASP3SENP7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10411192-B2 Aromatic amine compound, organic electroluminescent element and electronic device IDEMITSU KOSAN CO., LTD. (JP) 2019-09-10 US disclosed
US-20160181526-A1 AROMATIC AMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed
US-20160181526-A1 AROMATIC AMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2016-06-23 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10411192-B2 Aromatic amine compound, organic electroluminescent element and electronic device AOC2, PNMT, TYR PGR 2469/4885PLA2G2A 4251/4885PLA2G4A 4697/4885
US-20160181526-A1 AROMATIC AMINE COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT AND ELECTRONIC DEVICE AOC2, PNMT, TYR PGR 2469/4885PLA2G2A 4251/4885PLA2G4A 4697/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.